Young Li
Stock Analyst at Jefferies
(0.86)
# 4,183
Out of 5,147 analysts
8
Total ratings
60%
Success rate
-14.54%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Buy | $28 → $22 | $19.90 | +8.04% | 1 | Jan 28, 2026 | |
| TMDX TransMedics Group | Initiates: Buy | $145 | $145.26 | -0.18% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $7.48 | +20.32% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $83.67 | +37.44% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.07 | +16.82% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $25.47 | +135.57% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $14.36 | +220.33% | 1 | Jul 16, 2021 |
STAAR Surgical Company
Jan 28, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $19.90
Upside: +8.04%
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $145.26
Upside: -0.18%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $7.48
Upside: +20.32%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $83.67
Upside: +37.44%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.07
Upside: +16.82%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $25.47
Upside: +135.57%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $14.36
Upside: +220.33%